Copyright
©The Author(s) 2019.
World J Gastrointest Oncol. Dec 15, 2019; 11(12): 1182-1192
Published online Dec 15, 2019. doi: 10.4251/wjgo.v11.i12.1182
Published online Dec 15, 2019. doi: 10.4251/wjgo.v11.i12.1182
Table 1 Patient demographics
No. of patients, n = 15 | |
Age in yr, mean ± SD | 61.3 ± 12.8 |
Sex | |
M | 11 (73.3) |
F | 4 (26.7) |
Tumour site | |
Mid oesophagus | 1 (6.6) |
Lower oesophagus | 4 (26.7) |
Oesophageal-gastric junction | 10 (66.7) |
Histology | |
Adenocarcinoma | 11 (73.3) |
Squamous cell cancer | 3 (20.0) |
Other | 1 (6.7) |
Stage | |
I | 1 (6.6) |
II | 4 (26.7) |
III | 10 (66.7) |
Neo-adjuvant chemotherapy protocol | |
ECX | 7 (46.7) |
ECF | 3 (20) |
EOX | 1 (6.6) |
CX | 2 (13.3) |
CF | 2 (13.3) |
Table 2 Change in body composition from diagnosis to post neo-adjuvant chemotherapy following regular enteral feeding via jejunostomy, n = 15
Diagnosis | Post-chemotherapy | P value | |
Weight, mean ± SD, kg | 74.5 ± 14.1 | 74.8 ± 13.1 | 0.6591 |
BMI, mean ± SD, kg/m2) | 26.0 ± 3.8 | 26.1 ± 3.4 | 0.6231 |
Lumbar skeletal muscle index as cm2/m2, mean ± SD | 45.8 ± 8.0 | 43.5 ± 7.3 | 0.0481 |
Lumbar adipose tissue index as cm2/m2, mean ± SD, | 124.0 ± 53.7 | 124.6 ± 47.9 | 0.8781 |
Sarcopenic | 5 (33.3) | 9 (60.0) | 0.2192 |
Myosteatotic | 8 (53.3) | 8 (53.3) | 1.0002 |
Table 3 Individual values for changes in lumbar skeletal muscle index (cm2/m2) from diagnosis to post neo-adjuvant chemotherapy following regular enteral feeding via jejunostomy
Patient ID | Diagnosis | After neo-adjuvant chemotherapy |
Patient 1 | 45.86 | 43.20 |
Patient 2 | 46.27 | 42.87 |
Patient 3 | 44.44 | 40.65 |
Patient 4 | 24.25 | 27.50 |
Patient 5 | 47.97 | 43.77 |
Patient 6 | 54.85 | 53.80 |
Patient 7 | 41.05 | 35.91 |
Patient 8 | 43.79 | 53.48 |
Patient 9 | 47.00 | 45.39 |
Patient 10 | 54.47 | 50.53 |
Patient 11 | 40.50 | 39.20 |
Patient 12 | 39.15 | 36.71 |
Patient 13 | 52.26 | 44.59 |
Patient 14 | 56.74 | 53.76 |
Patient 15 | 48.84 | 42.05 |
Table 4 Individual values for changes in lumbar adipose tissue index (cm2/m2) from diagnosis to after neo-adjuvant chemotherapy following regular enteral feeding via jejunostomy
Patient ID | Diagnosis | After neo-adjuvant chemotherapy |
Patient 1 | 166.10 | 160.91 |
Patient 2 | 82.71 | 131.25 |
Patient 3 | 102.27 | 112.29 |
Patient 4 | 187.18 | 177.17 |
Patient 5 | 62.08 | 64.25 |
Patient 6 | 192.85 | 202.49 |
Patient 7 | 80.79 | 88.04 |
Patient 8 | 102.87 | 93.52 |
Patient 9 | 10.03 | 26.22 |
Patient 10 | 159.49 | 146.65 |
Patient 11 | 157.76 | 148.82 |
Patient 12 | 197.29 | 186.82 |
Patient 13 | 101.62 | 93.82 |
Patient 14 | 118.47 | 110.45 |
Patient 15 | 137.98 | 126.63 |
- Citation: Mohamed IM, Whiting J, Tan BH. Impact of regular enteral feeding via jejunostomy during neo-adjuvant chemotherapy on body composition in patients with oesophageal cancer. World J Gastrointest Oncol 2019; 11(12): 1182-1192
- URL: https://www.wjgnet.com/1948-5204/full/v11/i12/1182.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v11.i12.1182